Category: Press Release

Atlanta, December 16, 2014 – iMedX, a leading health information solutions company and a leader in medical documentation solutions, today announced that Trio Consulting, a management and technology consulting firm, has acquired the iMedX business unit, Alpha Transcription, a transcription firm serving VA hospitals and U.S. Department of Defense medical facilities. Terms of the deal were not disclosed.

Trio Consulting, a certified Small Business Administration (SBA) Service-Disabled Veteran-Owned company, focuses on leadership, technology, training and management consulting for veterans. The acquisition of Alpha Transcription supports Trio’s strategic goal in supporting veterans through medical transcription for VA hospitals and DoD medical facilities.

“Trio Consulting, a service-disabled veteran-owned small business, has a proud history of serving our nation’s veterans,” said David A. Turner Jr., CEO and Chairman of the Board, Trio Consulting. “With the acquisition of Alpha Transcription, we are very pleased to be able to support our fellow veterans through our support of the hard working members of the Veterans Administration. We feel pleased to significantly reconfirm our commitment to our fellow veterans.”

iMedX plans to use proceeds from the transaction to further invest in its core business which provides medical transcription technology and services, high-value medical coding services and data analytics solutions with a unique combination of best-of-breed technology and exceptional service.
”As an (SBA) Service-Disabled Veteran-Owned company, Trio Consulting brings a long-standing history and

significant commitment to veterans,” said iMedX CEO Christopher Foley. “Alpha Transcription couldn’t be in better hands to support the healthcare documentation needs of the VA and veterans.”

About iMedX

Founded in 2002, iMedX is a health information solutions company based in Atlanta, Georgia. Already known as an industry leader in medical transcription technology and services, iMedX has expanded its offerings in health information solutions to include high-value medical coding services and data analytics solutions.  The company employs approximately 2,700 people worldwide.

By employing leading-edge technology, custom solutions, best-in-class quality and consistent service excellence, iMedX helps drive positive results for its healthcare clients across the U.S.
Our complete focus is on supporting the success of our clients. Simply put, our client relationships mean everything to us.
Learn more at www.imedx.com.

For the Record Features iMedX Exclusive

For the Record magazine features a look at our humanology approach to medical transcription in a Web exclusive article, Software, People Combo a Hit, written by our own David Strite, senior vice president of operations.

The article discusses the trend towards technology in medical transcription and how the pendulum is swinging back in favor of people. iMedX developed the “humanology” approach to bringing people back into the process to bring efficiency (so doctors don’t have to edit) to the medical documentation process as well as quality assurance and continuous improvement to ensure the best capture of information for the patient record.

You can read more about how you can optimize medical documentation using humanology in his article here: http://bit.ly/1zPGiaz.

New App Enables Streamlined, Secure Capture of High Quality Medical Documentation Anytime, Anywhere

Atlanta, December 09, 2014 – iMedX, a leading health information solutions company and a leader in medical documentation solutions, today announced that it released the next version of iMedX Mobile™: an iOS app that enables highly secure, HIPAA-compliant medical documentation capture and access for physicians via iPhone or iPad anytime, anywhere. The solution is available in the Apple App store for free to physicians and other clinicians using iMedX documentation solutions.

The latest version of iMedX Mobile offers physicians and other healthcare providers a convenient and efficient way to document patient encounters using a highly secure, strongly encrypted app via iOS devices. The app provides physicians an efficient way to not only dictate their patient encounters but also interact with the patient schedule to ensure accuracy through a secure streamlined workflow.

“The new version of iMedX Mobile offers physicians the convenience and security they need to document their patient encounters using their preferred devices,” said Jeff Hopkins, VP of Engineering, iMedX. “Physicians and other clinicians are pressed for time in today’s fast-paced medical environment. They need easy-to-use options for dictation which do not compromise security or quality at their fingertips, anytime, anywhere. The iMedX mobile app for iOS offers physicians and other clinicians convenient dictation options with the encryption and streamlined workflows they need to make the best use of their time and ensure positive patient outcomes.”

iMedX Mobile enables physicians to dictate patient encounters via iPhone or iPad in a HIPAA-compliant environment. They simply select a patient via a schedule list and dictate their notes at their convenience using the encrypted app on the iOS device of their choice. The dictation then securely uploads through the iMedX cloud to be processed and added to the patient record. Further, iMedX does not require physicians to edit their dictations; iMedX provides back-end editing and other industry-leading best practices to ensure the highest quality medical transcription.

About iMedX

Founded in 2002, iMedX is a health information solutions company based in Atlanta, Georgia. Already known as an industry leader in medical transcription technology and services, iMedX has expanded its offerings in health information solutions to include high-value medical coding services and data analytics solutions.  The company employs approximately 2,700 people worldwide.

By employing leading-edge technology, custom solutions, best-in-class quality and consistent service excellence, iMedX helps drive positive results for its healthcare clients across the U.S.
Our complete focus is on supporting the success of our clients. Simply put, our client relationships mean everything to us.

Learn more at www.imedx.com.

Welcome to the new iMedX website. You are seeing big changes to the face of iMedX. I’d like to introduce you to iMedX and our approach: humanology.

Since the company was founded in 2002, we have built one of the leading companies in health information and clinical documentation with one of the highest client satisfaction ratings in the industry. We’d like to tell you a bit about us along with a new term that we use to describe our approach, humanology, on our new website.

What is humanology? iMedX fuses industry-leading technology with the most qualified people and processes to deliver the highest quality medical documentation around. Our people bring a higher level of critical thinking, expertise, and best practices to our work which can’t be achieved by technology alone. Plus, we deliver a consistently higher quality product to our customers. Our complete focus remains on supporting the success of our clients. Simply put, our client relationships mean everything to us. That is humanology.

So, I’d like to invite you to take a tour of our new website to learn more about us, humanology, and our offerings.

Chris Foley, CEO

iMedX, a leading health information solutions company and leader in medical documentation solutions, today announced that the company has made significant progress in the execution of its strategic plan, becoming a top three vendor in the medical documentation solutions business. iMedX has experienced more than 300 percent growth since June 2013, achieved through a combination of smart acquisitions and strong organic growth.

The medical transcription market is growing in the United States, driven by the implementation of Affordable Healthcare Act and the ICD-10 coding initiative. According to market research firm TechNavio the medical transcription market in North America is expected to reach US$30 billion by 2014 making it a high-growth market.

iMedX is seeing the new leadership team’s strategy of organic growth and growth through the acquisition of large and significant best-of-class companies come to fruition. CEO Christopher Foley, a successful clinical documentation industry veteran, joined iMedX in July 2013 with the specific goal of building one of the premier health information companies in the world.

“The medical documentation market is a high-growth market filled with a range of companies with varying levels of expertise, technology and customer service,” Foley said. “Based on our experience in building highly successful companies, we’re well on our way to achieving our growth goals and leadership with top-notch customer service and best-in-class solutions.”

In addition, iMedX has raised a new round of equity financing through both new and existing investors. The new financing enables iMedX to build out its clinical documentation and transcription business and to complete two significant strategic acquisitions of clinical documentation companies. The financing also will provide additional resources for iMedX’s future acquisition strategy in the health documentation solutions market, including medical transcription, medical coding and data analytics.

“Due to our strong financial partners and leadership, iMedX has struck the right combination of technology and services to make a significant impact in a crowded market,” Foley said. “We know that technology without service is not effective and have developed our solutions with that in mind.”

For example, the personalized iMedX Express transcription software and iMedX Mobile applications for iOS and Android make iMedX offerings among the most advanced in the industry. These new mobile applications will help physicians keep up with their clinical documentation demands.

“iMedX appreciates the continued support of our investors for this opportunity in the health information solutions market,” Foley said. “These investments validate our vision of the high-growth market and its long-term sustainability. Through our unmatched passion for excellence and innovation, iMedX strives to leverage our unique combination of customer service and best-in-class technology to lead the market.”

Third-Largest Medical Documentation Company Adds Talent and New Customers

Atlanta, November 07, 2014 – iMedX, a leading health information solutions company and a leader in medical documentation solutions, today announced that it has made the strategic acquisition of two medical documentation companies — Superior Global Solutions, Inc., based in Plano, TX, and Medwrite Inc., based in Anaheim, CA — for undisclosed terms.

iMedX, the third-largest company in the industry in terms of revenue, combines technology with exceptional customer service to deliver unparalleled solutions for medical documentation, medical coding services and data analytics solutions.

“These strategic acquisitions are a win-win for all – Superior Global, Medwrite, and most of all, our customers,” said iMedX CEO Christopher Foley. “Both companies complement iMedX’s growth strategy. As a part of iMedX, Superior Global and Medwrite customers will be able to access a broader set of technology solutions and our exceptional service. For iMedX, the acquisitions bring us world-class talent and marquis customers. We welcome these companies to the iMedX family.”

The medical documentation solutions industry continues to grow in the United States driven by the implementation of the Affordable Healthcare Act, the HITECH Act and the ICD-10 coding initiative. Acute care institutions and large physician practices look to companies like iMedX to help them work through their medical documentation challenges in the highly complex healthcare environment.

The latest iMedX strategic acquisitions were funded with a round of equity and debt financing through both new and existing investors late last year. The financing enables iMedX to build out its clinical documentation and transcription business and continues to fund significant strategic acquisitions to fulfill iMedX’s growth strategy and vision.